Insulin injections alleviate hyperglycemia in most patients with diabetes. However, they do not provide dynamic control of glucose homeostasis. Consequently, patients with longterm diabetes commonly develop life-threatening complications such as cardiovascular and kidney disease, neuropathy, and blindness. It has recently been shown that sustained independence from insulin injections can be achieved by transplantation of pancreatic islets into patients with diabetes [1] . Unfortunately, practical application of this clinical protocol is severely hampered by the shortage of islets available for transplantation. If functional β-cells and islets could be generated ex vivo, present severe islet shortage could be overcome. Another possible approach for restoration of islet cell mass is enhancement of endogenous regenerative capacity of endocrine pancreas. Recent results in rodents and humans suggest that pancreas has an extensive capacity to regenerate after injury [2] [3] [4] . In fact, it has been hypothesized that diabetes might result from β-cell destruction overpowering β-cell regeneration and that even a long time after the onset of 
the disease, β-cell regeneration might still take place [4] . It thus might be possible to restore β-cell mass in patients with diabetes by shifting the equilibrium between regeneration and destruction in the direction of regeneration.
Many adult mammalian organs contain a reservoir of tissue-specific stem and progenitor cells [5] . Throughout the life of an organism, stem and progenitor cells are used for replenishing the differentiated cell mass to compensate for cell loss during normal cell turnover and after organ damage. Although it is thought that cell replacement occurs primarily via differentiation of pre-existing resident organ-specific stem and progenitor cells, there are some notable exceptions. For example, it has been shown that adult mammalian liver can efficiently regenerate as a result of proliferation of mature hepatocytes [6] . Also, in lower vertebrates, limb regeneration after injury occurs via dedifferentiation of mature tissue into transient stem cells, which expand and redifferentiate to regenerate the missing limb [7] . Whether similar transitions occur in higher vertebrates remains to be determined.
During embryogenesis, the pancreas is derived from the endoderm [8] . Neural cells, on the other hand, are derived from ectoderm. Despite their different embryological origins, pancreatic and neural cells express many common enzymes and other markers and have similarities in developmental control mechanisms [8] [9] [10] [11] [12] [13] [14] . An intermediate filament protein, nestin, a marker of neural stem and progenitor cells [15] , is also expressed in pancreas. Recently it has been proposed that nestin may mark pancreatic stem or progenitor cells [13, 16, 17] . This claim was challenged, however, by others studies that suggest that nestin is expressed in pancreatic mesenchyme and not in the epithelium from which pancreatic endocrine cells are thought to originate [18] [19] [20] [21] [22] [23] .
It has been argued that in the mammalian pancreas, new hormone-producing cells arise either through islet cell replication or through differentiation from progenitor and stem cells via a process called islet neogenesis [3] . Because new islets often arise in close proximity to pancreatic ducts, it has been suggested that pancreatic stem or progenitor cells might reside within the ducts [24] . However, recent results do not support this hypothesis [25, 26] . Rigorous testing of the origins of cells that can give rise to new islet cells is complicated by the lack of specific markers for the putative pancreatic stem and progenitor cells and by the difficulty of following individual cells'fate in the pancreas. An in vitro differentiation system allowing generation of new pancreatic endocrine cells would greatly benefit this work [8, [27] [28] [29] .
In this study we present a new in vitro differentiation system derived from adult mouse islet-enriched fractions (IEFs). When IEFs are cultured on adhesive substrates, they first generate a heterogeneous population of proliferating cells. After aggregation, the IEF-derived cells form three-dimensional islet-like cell clusters (ILCCs), which produce insulin/C-peptide and other islet endocrine hormones, glucagons, and somatostatin. Our results show that new hormone-producing cells are actively generated in this in vitro system. Moreover, we show that embryonic-like cells exhibiting neural and stem cell properties arise in the IEF cultures. These findings uncover a previously unrecognized capacity of adult pancreas to acquire embryonic phenotype and to generate pancreatic and nonpancreatic progeny.
Materials and Methods

Cell Culture
Mouse IEF fractions (C57BL/6J and FVB/NJ3, both from Jackson Laboratory, Bar Harbor, ME) were isolated from pancreas perfused with collagenase V (Sigma, St. Louis) using described protocols [30] . Depending on the preparation, the islet content of the IEFs ranged from 60%-80% (as determined by staining with Zn 2+ binding agent, diphenyl thiocarbazone dithizone, Sigma). To monitor insulin production, small aliquots of the cell culture at different stages of development were removed for determination of intracellular C-peptide content. The cells were cultured as described [31, 32] , with some modifications. Specifically, the IEFs (500 cell clusters per 60-mm dish) were plated in tissue culturegrade dishes precoated overnight with polyornithine/bovine fibronectin (polyornithine 10 µg/ml, fibronectin 2 µg/ml, Sigma) and concanavalin A (1 µg/ml, Sigma) in Dulbecco's modified Eagle's medium with 10% fetal bovine serum (both from Invitrogen, Carlsbad, CA; stage 1; Fig. 1A ). After 48 hours in serum-containing medium, from 50%-80% of IEFs attach to the tissue culture dishes. At this time, the serum-containing medium was replaced with the serum-free insulin, transferrin, selenium, and fibronectin media [31] containing 20 ng/ml of basic fibroblast growth factor (bFGF; R&D systems, Minneapolis) and 1,400 U/ml of leukemia inhibitory factor (LIF; Chemicon, Temecula, CA). Serum-free medium was used throughout the remaining culture period. After an additional 7-10 days (stage 1), the cells were removed from tissue culture dishes using mild trypsin digestion for 5 minutes at 37ºC (0.05% trypsin/0.53 mM EDTA, Invitrogen) and replated at high density (2 ✕ 10 5 /cm 2 ) or low density (3 to 4 ✕ 10 4 /cm 2 ) on tissue culture plastic or glass coverslips precoated with poly-ornithine/laminin-1 (laminin at 1 µg/ml, Becton, Dickinson Labware, Bedford, MA) or polyornithine/fibronectin, as in stage 1, in N2 medium [31] containing B27 (Invitrogen), 10 mM nicotinamide (Sigma), and 20 ng/ml of bFGF. For stages 2 and 3, the cells were cultured for an additional 6-10 days; bFGF was added to the medium during the first 4-5 days of culture (stage 2) and later removed for the duration of the experiment (stage 3).
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BrdU Labeling and Pulse Chase Experiments
BrdU was dissolved in PBS and added to the cultures at a final concentration of 10 µM. The cells were labeled with BrdU in one 24-hour pulse (day 6) followed by culture for additional time without BrdU in the media. In other experiments, BrdU was added to the cultures for 2-, 6-, or 24-hour pulse followed by immediate cell fixation. For BrdU immunocytochemistry, the cells were treated with 2 M HCl for 45 minutes at room temperature, neutralized with 0.1 M sodium borate (pH 8.5) for 15 minutes, and reacted with primary and secondary antibodies using standard protocols.
C-Peptide Measurement and C-Peptide Release Assay
The total intracellular C-peptide content of the culture and Cpeptide concentration per microgram of cellular protein was determined using rat C-peptide RIA kit (Linco Research, Inc.). Protein concentration in the samples was determined using BioRad Protein Assay kit (Bio-Rad Laboratories, Hercules, CA) following the manufacturer's instructions. The Cpeptide release assay was carried out in static 15-minute incubations, as described previously [32] . The amount of intracellular C-peptide and C-peptide released in the medium in response to glucose was determined using C-peptide RIA kit, as above. The values of C-peptide released in the medium were normalized per microgram of intracellular protein for the corresponding samples. The results are presented as mean of triplicate samples each determined in duplicate measurements ± standard deviation.
Apoptosis Assay
Caspase-3 and -7 protease activity was determined using the Caspase-Glo 3/7 Assay Kit (Promega, Madison, WI) following the manufacturer's instructions. Briefly, the cells were washed in PBS, frozen at -80°C, and, after thawing, solubilized in Caspase-Glo 3/7 reagent containing luciferase and luminogenic substrate (Z-DEVD). The reactions were incubated at 37°C for 30 minutes, and the cleavage of the substrate by caspase-3 and -7 was detected using luminometer (BioOrbit, Turku, Finland). The readings for the blank controls were subtracted from the experimental readings, and the relative light units produced at different time points 
Reverse Transcription-Polymerase Chain Reaction
The total cellular RNA was isolated using RNEasy kit (Qiagen, Valencia, CA). To avoid a potential contribution from traces of genomic DNA to the polymerase chain reaction (PCR) signal, we removed traces of DNA from the RNA samples with DNA-free TM DNase (Ambion, Austin, TX).
The RNA was reverse transcribed into cDNA using Superscript II reverse transcriptase (RT; Invitrogen) and random hexamers (Invitrogen) according to the manufacturer's instructions. The PCRs were performed in 25 µl reaction volume using Taq DNA polymerase (Invitrogen). To additionally control for an unlikely contamination with genomic DNA, we included in our analysis the "RT (day 10)" samples ( Fig. 2 ). These were mock cDNA samples prepared using day 10 RNA, omitting RT from the cDNA reaction mixture. Moreover, when possible, the sequences of gene-specific primers were chosen to span introns. (Among all of the primers, only Bmi-1-specific and Sip1-specific primers do not span introns.) To determine the optimal cycle number in the linear range of PCR amplification, for each set of primers, the initial PCR reactions were carried out at several different cycle numbers. Also, to assure semiquantitative RT-PCR analysis, we first normalized cDNA concentration in different cDNA samples by relative expression of an internal control, 18S rRNA. We then chose the amount of input cDNA for other genes accordingly. The expected fragment sizes and the optimal PCR cycle numbers used were as follows: 18s rRNA, tcaagaacgaaagtcggagg and ggacatctaagggcatcaca (488), 20 cycles; insulin 1, tagtgaccagctataatcagag and acgccaaggtctgaaggtcc (288) 
Cell Counting
For cell counting, specific marker-positive cells were counted in 10 random microscopic fields. The results are presented as a mean of 10 counted fields ± standard deviation. When cells of interest were present in three-dimensional clusters, we counted them in individual optical sections in images captured by a laser confocal microscope (Zeiss LSM510). We spaced the counted optical sections in a given confocal Z stack, making sure not to count the same cell twice.
RESULTS
ILCCs Exhibit Phenotype of Rodent Islets
To examine the potential of adult mouse pancreas to generate new hormone-producing cells, we cultured IEFs using a modification of protocols previously shown to promote neural differentiation of central nervous system (CNS) stem cells and pancreatic differentiation of embryonic stem cells [31] [32] [33] . When freshly isolated IEFs are cultured on fibronectin in fetal bovine serum-free medium, in the presence of bFGF and LIF, they lose their three-dimensional architecture and generate morphologically heterogeneous rapidly proliferating cell populations ( Fig. 1A ; also see Materials and Methods for detailed description of the culturing protocol). Notably, cells with neural-like morphology are a common feature of stage 1 cultures (see below). When the cells are replated at high density on laminin-1 at the end of stage 1, they gradually aggregate to form three-dimensional ILCCs. If, however, the same cells are replated at low density on either laminin-1 or fibronectin or at high density on fibronectin, the ILCC formation is inefficient (Figs. 1B, 1C) . If the cells are not replated at the end of stage 1 but are continually maintained on fibronectin, no ILCC formation is observed. Instead, neural-like cells become a predominant cell type (unpublished data).
To quantify the effect of different culture conditions on ILCC differentiation, we compared intracellular C-peptide concentration after culturing stage 2 cells at high versus low density and on laminin-1 versus fibronectin. We chose to measure C-peptide rather than insulin to eliminate a potential contribution to the signal from the bovine insulin present in the culture media [34] . Because, as a result of proteolytic 1074 Stem Cells and Differentiation in Pancreas processing of proinsulin, insulin and C-peptide are generated in equimolar quantities, the C-peptide production is a reflection of insulin production. When measured at the end of the culture in two independent experiments, the concentration of C-peptide in high-density laminin-1 cultures is 2-to 3.5-times higher than its concentration in high-density fibronectin cultures (Fig. 1B) . If the cells are cultured on fibronectin at low density, the C-peptide concentration drops an additional 2-to 10-fold. Furthermore, when cells are cultured at low density on laminin, the concentration of C-peptide is reduced two to five times compared with cultures at high density on laminin. These results suggest that both cell-cell and cell-extracellular matrix interactions may be playing a functional role in this differentiation system. Given our finding that high-density laminin-1 cultures result in the best outcome, we used these conditions for all of the subsequent experiments described below.
To investigate the dynamics of C-peptide production during the culture, we compared intracellular C-peptide concentration per microgram of protein and total intracellular Cpeptide content of fresh IEFs with those of cultured IEFs at the end of stages 1 and 3 (the latter value reflects the amount of C-peptide present in the whole-cell preparation at a given stage of culture). The results of three independent experiments (Figs. 1D, 1E ) demonstrate that at the end of stage 1, the cultures become largely depleted of C-peptide. Our results suggest that increase in the rate of apoptosis as well as reduced hormone production by the IEFs is responsible for the observed C-peptide depletion of late stage 1 cultures (see below). The reduction in C-peptide level is followed by its increase at the end of the culture.
Immunocytochemical analysis of C-peptide and β cell-specific transcription factor PDX-1 [35, 36] shows that, similar to native β cells, C-peptide + cells exhibit nuclear localization of PDX-1 (Fig. 1C, right side) . Using immunocytochemistry, we have additionally found that other islet hormones, glucagon and somatostatin, are also produced by the ILCCs (unpublished data and Fig. 3B ). Our analysis of functional maturation of the ILCCs shows that they release C-peptide in response to glucose with kinetics characteristic of normal islets (Fig. 1F) . At 16.7 mM glucose, the release of C-peptide is nearly fivefold higher than that at the baseline, at 5 mM glucose. Expression of islet hormone-specific mRNAs during different stages of culture development was analyzed by RT-PCR (Fig. 2) . In contrast to the C-peptide levels, the steadystate levels of these mRNAs do not change significantly during the culture period. Enumeration of C-peptide, glucagon, and somatostatin-expressing cells (Tables 1A and 1B) shows that the percentage of C-peptide-expressing cells in the culture increases between the end of stages 1 and 3. Also, at the end of stage 3, the relative ratios of different hormoneexpressing cells approximate those of the rodent islets. In summary, these results demonstrate that ILCCs have phenotypic characteristics similar to those of native islets.
Extensive Cell Proliferation and Apoptosis Take Place during Stage 1
We next investigated the extent of contribution of the input IEF cell pool to the ILCCs obtained at the end of the culture. To this end, we measured cellular proliferation and apoptosis during the course of the IEF cultures. For cell proliferation analysis, the cells were pulsed for 6 hours with thymidine analog, BrdU, which incorporates into DNA of the replicating cells. After the pulse, the cells were fixed, and the incorporated BrdU was detected using immunocytochemistry with BrdU-specific antibody. Quantitative analysis of BrdU incorporation ( Fig. 2A) cultures proliferate throughout the culturing period. The peak of proliferation occurs between days 4 and 6 of stage 1. During this time window, 40%-50% of all cells in the culture become BrdU positive after 6h pulse. Most of the proliferating cells are found either in or around the flattened cells clusters, which lost their three-dimensional architecture. Occasionally we find proliferating cells at the periphery of three-dimensional clusters. Only few proliferating cells are detected within an interior of the three-dimensional clusters ( Fig. 2A , right side of the panel; also see Fig. 2A ). The level of apoptosis was estimated using CaspaseGlo TM luminescent assay (Promega), which measures caspase-3 and caspase-7 activity in cell lysates. Caspase-3 and -7 proteases are key effectors of apoptosis in mammalian cells [37] . The results (Fig. 2B) show that the input IEF population contains a large proportion of apoptotic cells. Also, early stage 1 cultures undergo active apoptosis. Moreover, we found that in early stage 1 cultures, a large fraction of C-peptide-expressing cells coexpress caspase 3 (Fig. 2B , right side of the panel). Overall, the results of BrdU incorporation and apoptosis analysis demonstrate that cell proliferation accompanied by extensive apoptosis takes place during stage 1 of IEF culture. They suggest that stage 3 cultures become considerably depleted of the input IEF cells.
New Islet-Like Cells Are Generated in IEF Cultures
To examine if new C-peptide/insulin-producing cells are generated during the course of IEF culture, we carried out BrdU pulse and BrdU pulse chase analysis of C-peptide- (Fig. 3A and unpublished data). These double-labeled cells appear primarily within flattened epithelial clusters, which are a common feature of early stage 1 cultures. These double-labeled cells are often found at the clusters' periphery, and they appear to exhibit a reduced immunoreactivity to C-peptide antibody. These results indicate that β cells may be losing C-peptide expression as they divide in culture. The scheme of BrdU pulse chase analysis is shown at the top of Figure 3B . The cells were pulsed with BrdU during stage 1 for 24 hours and then were maintained without BrdU for the remainder of the experiment. The results of this experiment (Fig. 3B) demonstrate that a subpopulation of stage 3 C-peptide, glucagon, and somatostatin-expressing cells is derived from the proliferating cells. In particular, our quantitative analysis shows that between 20% and 40% of stage 3 hormone-expressing cells are derived from proliferating cells (Tables 1A and 1B) . We obtained similar results in at least three independent experiments. In summary, the results of BrdU pulse and BrdU pulse chase analysis indicate that new hormone-producing cells are generated during the course of the IEF cultures.
Stage 1 Cultures Express a Wide Range of Embryonic Neural and Stem Cell Genes
As described above, we observe morphologically heterogeneous neural-like cells in stage 1 cultures. We decided to examine if indeed these cells express neural-specific markers. In addition to the neural progenitor cell marker, nestin, we examined a marker of astrocytes, GFAP [38] ; a marker of early neurons, neuronal-specific β III subunit of β-tubulin recognized by TUJ1 antibody [39] ; a marker of embryonic neural crest, transcription factor Sox10 [40] ; and a marker of oligodendrocytic progenitors, O4 [41] . We also examined expression of neuroepithelial and radial glial cell marker of embryonic CNS, RC-2 [42, 43] . Notably, in the embryonic brain, radial glia is thought to possess stem cell properties [44, 45] . The results of immunocytochemical analysis (Fig.  4) show that all the examined markers are abundantly expressed at the end of stage 1 in a partially overlapping pattern. For example, we detect distinct subpopulations of nestin + cells expressing TUJ1 and GFAP. Most O4 + cells found within cell clusters do not coexpress GFAP. We found that, similar to adult brain [46] , adult IEFs do not express RC-2 (unpublished data). In contrast, an abundant population of RC-2 + /nestin + cells is found in late stage 1 cultures (Figs. 4E,   4F ). Reminiscently of their arrangement in the embryonic brain, these cells are organized in parallel cell bundles. Moreover, similarly to mouse CNS, most RC-2 + cells do not express GFAP [47] (Fig. 4F) . The results of BrdU lineage tracing analysis show that most TUJ1, RC-2, nestin, and GFAP cells are derived from proliferating cell populations (Table 1B) and thus are generated de novo during the course of the culture. Neural and stem cell phenotype of IEF cultures was analyzed additionally by RT-PCR (Fig. 5) . The results demonstrate that expression of GFAP, nestin, and astrocytic marker,
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2+ binding protein S100β [48] , peaks at the end of stage 1 and falls at the end of the culture. This pattern of expression was also confirmed by immunocytochemistry (unpublished Choi, Ta,Atouf et al.
1079 Figure 5 . IEF cultures express a wide range pancreatic, neural, and stem cell-specific genes. Time-course RT-PCR analysis of pancreatic, neural, and stem cell gene expression. Negative control PCR amplifications, "RT (day 10)," were carried out with mock cDNA samples, which were prepared with day-10 RNA, omitting RT from the cDNA reaction mixture. The results in the two panels shown were obtained with two independent RNA time courses. Similar results for the markers shown were obtained in at least three independents experiments. Abbreviations:GFAP, glial fibrillary acidic protein; IEF, islet-enriched fraction; RT-PCR, reverse transcriptase-polymerase chain reaction. data). Having found neural embryonic-like cells in these adult pancreatic cultures, we decided to expand the RT-PCR analysis to a wider panel of stem cell-specific and other early developmental genes (Table 2) . Our results show that by the end of stage 1, the IEF cultures initiate expression of many genes associated with embryonic and stem cell phenotype. For example, we detect a marker of side population, the ABC pump Bcrp1/Abcg2 [49] , which is found in a variety of multipotent stem cell types. Although the day 0 cDNA preparation used for the RT-PCR analysis shown in Figure 5 is negative for Bcrp1/Abcg2, we detected Bcrp1/Abcg2 signal in other day-0 cDNA preparations. Further, Bmi1, a polycombgroup transcriptional repressor required for the maintenance of adult stem cells in several tissues [50, 51] , is upregulated during stage 1. Interestingly, we also detect the Bmi1 signal in IEFs before culture initiation. To our knowledge, expression of Bmi1 in adult pancreas has not been previously documented. Transient induction of markers of ES cells/preimplantation embryo, Oct-4, nanog, Sox2, and FoxD3 [52] [53] [54] [55] [56] is particularly intriguing. It suggests that a short-lived ES-like subpopulation may be present in late-stage 1 IEF cultures. Because, in addition to expression in the embryonic stem cells, Sox2 and FoxD3 are also expressed in embryonic neural crest, perhaps a portion of Sox2 and FoxD3 signal can be attributed to a neural crest-like cell population that arises in the IEF cultures. In fact, we have found that other neural crest-specific mRNAs, Twist, Snail, Slug, Sip1, and Sox10 (see also Fig. 4C ) [40, [57] [58] [59] [60] , are induced during stage 1 (Fig. 5) . We reproducibly observed a similar mRNA expression pattern for all of the examined markers in different independent IEF in vitro culture experiments.
Discussion
Pancreatic Phenotype of IEF Cultures
In this work, we show that adult mouse IEFs cultured in serum-free medium in the presence of LIF and bFGF can generate actively proliferating cell populations. When plated at high density on laminin-1, these cells give rise to the three-1080 Stem Cells and Differentiation in Pancreas Table 2 . Neural and stem cell markers shown in Figure 5 Gene Function Reference dimensional ILCCs expressing insulin, glucagon, and somatostatin. Upon glucose stimulation, the ILCCs secrete C-peptide with kinetics approximating those of the native islets. We also show that the C-peptide-expressing β-like cells coexpress PDX-1 and that intracellular C-peptide concentration of stage 3 cultures is within a range of that of the input IEFs, implying that ILCCs produce physiological levels of C-peptide/insulin. In individual experiments, the final intracellular C-peptide concentration of stage 3 cultures varied more than fivefold to sixfold. It is likely that these differences result from experiment-to-experiment cell-type variability of the input IEFs and from unequal proliferation/ differentiation/survival capacity of the different cell types. Thus, even small differences in the initial composition of IEFs would translate into large differences in the outcome of the culture.
We chose to use heterogeneous islet-containing IEFs rather than islet-depleted pancreatic fractions used by several other investigators [61, 62] . First, islets themselves may contain pancreatic progenitor cells [25, 29] . Second, islet endocrine cells may have a capacity to undergo cell division and to generate new endocrine-like cells [26, 63, 64] . Third, cell-cell interaction between islet and extra-islet cell types may promote pancreatic differentiation and morphogenesis. We cannot rule out that a fraction of input endocrine cells survives until the end of the culture. However, because of active apoptosis and cell proliferation during stage 1, our results strongly suggest that such contamination should not be a major source of endocrine-like cells comprising the ILCCs. Most important, the BrdU pulse chase analysis demonstrates that a substantial portion of hormone-expressing cells detected at the end of the culture is generated de novo. Our culturing protocol in the current form does not allow an overall expansion of hormone-producing cell mass, i.e., the Cpeptide level and the concentration at the beginning and at the end of the culture are similar. Clearly, for practical applications to expansion of islets in vitro, it will be important to overcome this limitation. Nevertheless, the lack of hormone cell expansion does not diminish the value of this in vitro differentiation system as an experimental tool to investigate the mechanisms of generation of new endocrine pancreatic cells.
Neural and Stem Cell Phenotype of IEF Cultures
We have found that in parallel with the ILCCs, new neuronaland astrocytic-like cells are generated in the IEF cultures. By varying cell plating density and extracellular matrix composition during stages 2 and 3, we can enrich cultures for neural versus islet-like cell types. Whereas low cell density and fibronectin favor generation of neural cells, high cell density and laminin-1 favor generation of islet-like cells. Given that we have not detected significant expression of markers of mature neurons (unpublished data); we conclude that most neuronal-like cells are developmentally immature. This immaturity is not surprising-after all, we made no attempt to optimize culture conditions to promote terminal neuronal differentiation.
Similarly to the adult mammalian CNS, in which RC-2 is not expressed [46] , we detected no RC-2 immunoreactivity in the IEFs before culture initiation. Conversely, the RC-2 + /nestin + cells were abundant in late stage 1 cultures. Also present at the end of stage 1 was a constellation of embryonic stem cell, multipotential stem cell, and embryonic neural crest mRNAs. Notably, one of the neural markers, Sox10, was recently identified in the embryonic pancreas but not in the adult pancreas [65] . Collectively, these results strongly suggest that in late-stage 1 IEF cultures, there exists a subpopulation of cells with embryonic and multipotential stem cell properties. Although expression of several neural and embryonic stem cell mRNAs is drastically reduced during ILCC morphogenesis, expression of neural crest mRNAs, Slug, Snail, Twist, and Sox10 remains high. Sustained expression of these embryonic genes suggests that a fraction of cells still retain their immature phenotype at the end of the culture. The embryonic and stem-like cell types that we found in the adult pancreatic cultures have not been described before. These findings were entirely unexpected. It will be important to elucidate the mechanisms responsible for generation of these cells, such as whether these cells arise through an expansion of a small population of stem cells pre-existing in adult pancreas or are derived from mature cell types. It will also be important to investigate the nature of proliferating cells giving rise to the endocrine-like cells. First, these cells may originate from hormone-negative pancreatic stem/progenitor cells residing in the pancreas. Second, similarly to the situation in adult liver [6] , and as recently reported in adult mouse pancreas [26] , in our cultures mature endocrine cells may replicate and generate new endocrine-like cells. Third, the new cells may be derived from mature endocrine cells through dedifferentiation and redifferentiation in a manner similar to limb regeneration in lower vertebrates [7] . In fact, our results of BrdU pulse analysis of C-peptide-expressing cells are compatible with the two latter models.
The observed difference between the v-shaped kinetics of C-peptide and the flat kinetics of insulin and other hormone-specific mRNA expression also could be explained within the context of the two latter models. For example, one could speculate that endocrine cells replicating during stage 1 may maintain the rate of islet-specific gene transcription but downregulate translation of the islet-specific genes. This Choi, Ta,Atouf et al. translational inhibition is then followed by the recovery of islet-specific translation during stages 2 and 3.
Finally, our work raises questions about possible lineage relationships between the late stage 1 stem-like cells, neural cell types, and hormone-producing cells. Specifically, do these cell types arise from a common progenitor, through interconversion via transdifferentiation, or independently from each other? Because the input cell population of the IEF cultures is heterogeneous, the conclusive answers to these questions could only come from lineage tracing and clonal analysis. This said, independent of whether the stem-like, neural, and pancreatic cells are related to each other, this work establishes a novel model system to investigate the mechanisms of generation of new endocrine hormone-producing cells and uncovers a previously unknown potential of adult pancreas to give rise to cells with multipotential stem cell and neural properties. We anticipate that these findings will have important implications for our understanding of the mechanisms of pancreatic development and regeneration.
